Categories Earnings, Technology

Earnings Summary: Highlights of NetApp’s (NTAP) Q1 2026 report

NetApp, Inc. (NASDAQ: NTAP), a provider of intelligent data infrastructure, has reported financial results for the first quarter of fiscal 2026

  • First-quarter revenue edged up 1% to $1.56 billion from $1.54 billion in the comparable period of FY25
  • All-flash array revenue grew 6% year-over-year to $893 million in Q1, for an annualized net revenue run rate of $3.6 billion
  • First-party and marketplace Public Cloud storage services revenue grew 33% year-over-year in the July quarter
  • Net income declined to $233 million or $1.15 per share in Q1 from $248 million or $1.17 per share last year
  • Total billings were $1.51 billion in the first quarter, up 4% year-over-year — the seventh consecutive quarter of year-over-year growth
  • Cash provided by operations rose to a record high of $673 million in Q1; free cash flow was $620 million
  • During the first quarter, the company returned $404 million to stockholders through share repurchases and cash dividends

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

After a rollercoaster year, is Tesla (TSLA) stock a good bet?

In recent years, Tesla's (NASDAQ: TSLA) stock has often swung between record highs and sharp corrections, reflecting shifts in investor sentiment, broader economic conditions, and changes in its financial performance.

Dollar Tree (DLTR), Dollar General (DG): Discount stores remain key gainers in a value-conscious landscape

Discount retailers Dollar Tree, Inc. (NASDAQ: DLTR) and Dollar General Corporation (NYSE: DG) have seen their stocks gain more than 30% in the past three months. The dollar stores continue

Everything you need to know about Aktis Oncology’s upcoming IPO

IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top